<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0555278" disease_type="Neoplastic Process" abbrv="">Cerebral Metastases</z:e> are diagnosed in approximately 20-30% of patients with <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumours</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Because of the improvement of central <z:mp ids='MP_0008912'>nervous</z:mp> system imagining technology and of the newly effective therapeutic schemes, the incidence of this particular type of cerebral lesion tends to increase </plain></SENT>
<SENT sid="2" pm="."><plain>In this retrospective study the authors review the patients admitted in the Neurology, Neurosurgery and Medicine departments and in the outpatient chemotherapy consultation, with a diagnosis of <z:e sem="disease" ids="C0555278" disease_type="Neoplastic Process" abbrv="">cerebral metastases</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Sex and age, neurologic symptoms at presentation, neuroradiologic findings, <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumour</z:e> origin, treatment outcomes and prognosis were evaluated in this population </plain></SENT>
</text></document>